Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 8-K Event Executive or director change
  2. 10-K Report Annual Report
  3. 8-K Event Results of operations
  4. SC 13G Stake Amended Statement of Ownership
  5. 8-K Event Executive or director change
  6. 4 Open-market buy Director bought 379 shares at an average $2.24 ($849)
  7. 4 Open-market buy Director bought 667 shares at an average $2.23 ($1,487)
  8. 4 Open-market buy Director bought 1,550 shares at an average $2.22 ($3,447)
  9. 4 Open-market buy Director bought 3,050 shares at an average $2.22 ($6,778)
  10. 4 Open-market buy Director bought 420 shares at an average $2.37 ($996)
  11. 4 Open-market buy Director bought 651 shares at an average $2.37 ($1,543)
  12. 4 Open-market buy Director bought 1,365 shares at an average $2.37 ($3,236)
  13. 4 Open-market buy Director bought 2,205 shares at an average $2.37 ($5,227)
  14. 8-K Event Other events
  15. 4 Open-market buy Director bought 500 shares at an average $2.49 ($1,247)
  16. 4 Open-market buy Director bought 775 shares at an average $2.49 ($1,933)
  17. 4 Open-market buy Director bought 1,625 shares at an average $2.49 ($4,054)
  18. 4 Open-market buy Director bought 2,625 shares at an average $2.49 ($6,549)
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 13 of 52 · 1,039 filings